Alnylam expands hepatic infectious disease pipeline
Specifically, in a presentation at the American Association for the Study of Liver Diseases (AASLD) meeting, the company announced it has added ALN-HDV, an RNAi therapeutic targeting the
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Eli Lilly and Company’s (Lilly) olomorasib as a potential treatment for adults with advanced pancreatic cancer who have already received at least one prior systemic therapy.
Stellar is a manufacturer of KLH, an immune-stimulating protein widely used as a carrier molecule in the development of immunotherapies. Spain-based Araclon is majority-owned by global healthcare firm
Selinexor works by inhibiting the nuclear export protein XPO1, leading to the accumulation of tumor suppressor proteins in the cell nucleus, which subsequently reinitiates and amplifies their tumor